Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AMG 162 vs IV Bisphosphonates in Advanced Cancer with Bone Metastases
NCT00104650Phase 2Completed
- Sponsor
- Amgen
- Start
- Jan 2005
- Primary completion
- Jan 2008
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
01
Overview
A Phase 2 trial of denosumab in bone metastases, sponsored by Amgen. Started Jan 2005; status: completed.
02
Drugs
denosumab
03
Conditions
bone metastases
Beyond the preview
Go deeper on NCT00104650.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00104650.